Results 21 to 30 of about 163,785 (367)

Heart Failure with Preserved Ejection Fraction [PDF]

Current Emergency and Hospital Medicine Reports, 2019
Heart failure with preserved ejection fraction (HFpEF), formerly known as diastolic heart failure, is a chronic disease that affects millions of people around the world.
Ryan, Abigalle
core   +6 more sources

Heart Failure with Preserved Ejection Fraction

European Cardiology Review, 2008
Definitions and Historical Considerations – The Misleading Role of Ejection Fraction Chronic heart failure (CHF) is a heterogeneous syndrome with a complex pathophysiology.
G. Keulenaer, D. Brutsaert
semanticscholar   +3 more sources

One-year outcomes after transcatheter insertion of an interatrial shunt device for the management of heart failure with preserved ejection fraction [PDF]

, 2016
Background—Heart failure with preserved ejection fraction has a complex pathophysiology and remains a therapeutic challenge. Elevated left atrial pressure, particularly during exercise, is a key contributor to morbidity and mortality.
Bergmann, Martin, Burkhoff, Dan, Doughty, Robert, Feldman, Ted, Hasenfuß, Gerd, Hausleiter, Jorg, Hayward, Christopher, Jondeau, Guillaume, Kaye, David M., Kolodziej, Adam, Muller, David, Neuzil, Petr, Penicka, Martin, Petrie, Mark C., Ponikowski, Piotr, Post, Martijn C., Raake, Philip, Rosenberg, Mark, Silvestry, Frank E., Trochu, Jean-Noël, van Veldhuisen, Dirk J., Walters, Darren, Walton, Antony, Westenfeld, Ralf   +23 more
core   +14 more sources

Ventricular-arterial uncoupling in heart failure with preserved ejection fraction after myocardial infarction in dogs - invasive versus echocardiographic evaluation [PDF]

, 2010
Heart failure with preserved left ventricular ejection fraction and abnormal diastolic function is commonly observed after recovery from an acute myocardial infarction.
Myrielle Mathieu, Bachar El Oumeiri, Karim Touihri, Ielham Hadad, Maryam Mahmoudabady, Philippe Thoma, Thierry Metens, Jozef Bartúnek, Guy R. Heyndrickx, Serge Brimioulle, Robert Naeije, Kathleen Mc Entee   +11 more
openalex   +5 more sources

Cardiopulmonary Test As A Component in the Diagnostic Algorithm for Heart Failure with Preserved Left Ventricular Ejection Fraction in Patients with Atrial Fibrillation [PDF]

Клиническая практика, 2023
Background: Patients with heart failure with preserved ejection fraction account for more than half of all hospitalizations because of heart failure.
Alexander S. Zotov, Elena S. Gorbacheva, Irina A. Mandel, Emil R. Sakharov, Oleg O. Shelest, Aleksandr V. Troitskiy, Robert I. Khabazov   +6 more
doaj   +1 more source

Clinical characteristics and outcomes of heart failure with preserved, mildly reduced, and reduced ejection fraction: A 6-month follow-up study

Medical Journal of Babylon, 2022
Background and Objective: Heart failure is a major public health problem with 64.3 million people affected all over the world, and it is an important cause for hospital admission and mortality.
Goran Adnan Rahman, Abdulkareem Abdulwahab Al-Othman   +1 more
doaj   +1 more source

Interpretation of the Essential Updates in 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure [PDF]

Zhongguo quanke yixue, 2022
The American Heart Association (AHA) , American College of Cardiology (ACC) and Heart Failure Society of America (HFSA) jointly released the 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure (hereinafter referred to as the 2022 Guideline) .
Yifang GUO
doaj   +1 more source

Inflamed adipose tissue: A culprit underlying obesity and heart failure with preserved ejection fraction

Frontiers in Immunology, 2022
The incidence of heart failure with preserved ejection fraction is increasing in patients with obesity, diabetes, hypertension, and in the aging population. However, there is a lack of adequate clinical treatment.
Chenyu Li, Donglu Qin, Jiarui Hu, Yang Yang, Die Hu, Bilian Yu   +5 more
doaj   +1 more source

Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.

New England Journal of Medicine, 2022
BACKGROUND Sodium-glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of hospitalization for heart failure and cardiovascular death among patients with chronic heart failure and a left ventricular ejection fraction of 40% or less.
S. Solomon, J. McMurray, B. Claggett, R. D. de Boer, D. DeMets, Adrian F. Hernandez, S. Inzucchi, M. Kosiborod, C. Lam, F. Martinez, Sanjiv J. Shah, Akshay S. Desai, P. Jhund, J. Bělohlávek, C. Chiang, C. Borleffs, J. Comín-Colet, D. Dobreanu, J. Drożdż, J. Fang, M. Alcocer-Gamba, Waleed Al habeeb, Yaling Han, Jose Walter Cabrera Honorio, S. Janssens, T. Katova, M. Kitakaze, B. Merkely, E. O’Meara, J. Saraiva, S. Tereshchenko, J. Thierer, M. Vaduganathan, O. Vardeny, S. Verma, V. Pham, U. Wilderäng, Natalia Zaozerska, E. Bachus, D. Lindholm, Magnus Petersson, A. Langkilde   +41 more
semanticscholar   +1 more source

Current diagnostic algorithms for chronic heart failure with preserved left ventricular ejection fraction

Zaporožskij Medicinskij Žurnal, 2023
Chronic heart failure remains one of the main causes of mortality and reduced life quality both in Ukraine and around the world. More than 50 % of all patients with chronic heart failure are those with preserved left ventricular ejection fraction.
Ya. Yu. Maistrovych, M. Yu. Kolesnyk
doaj   +1 more source